Funding for this research was provided by:
Merck Sharp and Dohme (NA)
Text and Data Mining valid from 2019-09-14
Received: 18 June 2019
Accepted: 5 September 2019
First Online: 14 September 2019
Ethics approval and consent to participate
: This study was approved by the Medical Ethics Committee of the Academic Medical Center in Amsterdam. All patients provided written informed consent.
: Not applicable
: DB is currently an employee of UCB Pharma. LJJvM and HMdJ declare that they have no competing interest. MGHvdS has been an advisor for Abbvie and Novartis and received research grants from Janssen, Eli Lily, and Novartis. The department of MK is supported by Novartis, Abbvie, Pfizer, Roche, Lilly, and BMS, and MK has been an advisor for Novartis and Abbvie. MTN received research grants, consultation, and/or speaking fees from Abbvie, BMS, Celgene, Eli Lilly, Janssen, MSD, Mundipharma, Novartis, Pfizer, Roche, Sanofi, and UCB Pharma. AWRvK received speaker fees from Celgene, Novartis, Eli Lilly, and Janssen and received research support from MSD and Janssen.